[시장보고서]결찰기 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 최종 용도별, 시술 유형별, 지역별, 부문별 예측(2025-2030년)

결찰기 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 최종 용도별, 시술 유형별, 지역별, 부문별 예측(2025-2030년)

Ligation Devices Market Size, Share & Trends Analysis Report By Product (Appliers, Accessories), By Application (Gynecology, Cardiothoracic), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1611234

리서치사 : Grand View Research

발행일 : 2024년 11월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,858,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,347,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,324,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

결찰기 시장 성장과 동향

Grand View Research, Inc의 최신 보고서에 따르면, 세계 결찰기 시장 규모는 2030년까지 18억 달러에 달할 것으로 예상되며, 2025-2030년 동안 7.0%의 CAGR을 기록할 것으로 예상됩니다. 이 시장은 주로 소화기 관련 질환의 발병률 증가와 최소침습적 시술의 채택 증가에 의해 주도되고 있습니다. 또한, 결찰기를 필요로 하는 내시경 검사 부문의 기술 발전도 성장을 촉진할 것으로 예상됩니다. 또한, 소화기 시술 부문의 의료비 지출 증가도 시장을 견인하고 있습니다. 다양한 소화기 질환 및 만성질환에 취약한 노년층의 증가가 수요 증가에 기여할 것으로 예상됩니다. 미국 국립보건원에 따르면 2015년 65세 이상 인구는 6억 1,700만 명이며, 2050년에는 16억 명에 이를 것으로 예상됩니다.

관상동맥 우회술, 대동맥판막치환술, 승모판막치환술과 같은 개복수술에서 결찰기 사용이 증가함에 따라 결찰기 시장의 성장이 촉진될 것으로 예상됩니다. 2016년 미국에서 156,931건의 관상동맥 우회술(CABG)이 시행되었습니다. 또한, 연구 개발 비용의 증가와 함께 유리한 상환 정책도 시장 성장에 박차를 가하고 있습니다.

결찰기 시장 보고서 하이라이트

제품별로는 액세서리 부문이 저렴한 가격과 높은 사용 빈도로 인해 2024년 액세서리 부문이 가장 큰 시장 점유율을 차지했습니다.
어플리케이터별로는 재사용 가능한 어플리케이터가 최소침습수술과 개복수술 모두에 사용되면서 가까운 미래에 계속 우위를 차지할 것으로 예상됩니다.
용도별로는 소화기 및 복부 수술 부문이 고령화에 따른 소화기 질환의 유병률 증가로 인해 2018년 가장 큰 시장 점유율을 차지했습니다.
시술 유형별로는 최소침습적 시술 부문이 2024년 67.1% 이상의 가장 큰 시장 점유율을 차지했으며, 예측 기간 동안에도 우위를 유지할 것으로 예상됩니다.

지역별 시장 점유율 분석, 2024년과 2030년
지역별 시장 대시보드
세계 지역 시장 현황
시장 규모와 예측 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 구도

주요 시장 진출 기업의 최근 동향과 영향 분석
기업/경쟁 분류
- 이노베이터
벤더 상황
- 주요 판매대리점과 채널 파트너 리스트
- 주요 기업의 시장 점유율 분석, 2024년
- Medtronic
- Johnson & Johnson Services, Inc.
- The Cooper Companies, Inc.
- CONMED Corporation
- B. Braun SE
- Teleflex Incorporated.
- Olympus Corporation

ksm

영문 목차

영문목차

Ligation Devices Market Growth & Trends:

The global ligation devices market size is expected to reach USD 1.8 billion by 2030 according to a new report by Grand View Research, Inc., registering a 7.0% CAGR from 2025 to 2030. The market is primarily driven by the increasing incidence of digestive system related diseases and increasing adoption of minimally invasive procedures. Technological advancements in the field of endoscopy which require ligation devices is also expected to drive the growth. Moreover, increasing healthcare spending in the field of gastrointestinal procedures is also fueling the market. Rise in the geriatric population prone to various digestive and chronic diseases is projected to contribute to the rising demand. According to the National Institutes of Health, in 2015, there were 617 million people over the age of 65 years and the number is projected to reach1.6 billion by 2050.

Increasing use of ligation devices in open surgeries such as coronary artery bypass, aortic valve replacement, and mitral valve replacement is expected to propel growth of the ligation devices market. According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database, in U.S., 156,931 Coronary Artery Bypass Grafting (CABG) procedures were performed, in 2016. In addition, favorable reimbursement policies along with rising R&D expenditure is also adding to the growth of the market.

Ligation Devices Market Report Highlights:

By product, accessories segment accounted for the largest market share in 2024, owing to low cost and high usage of the product
By applier, reusable appliers are projected to continue dominating in near future owing to the rising use in both minimally invasive and open procedures
By application, gastrointestinal and abdominal surgery segment captured the largest market share in 2018, owing to increasing prevalence of age-related digestive diseases
Based on procedure type, minimally invasive procedures segment accounted for the largest market share of more than 67.1% in 2024 and is expected to maintain its dominance during the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.1. Segment Definitions
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Procedure Type
- 1.1.4. End Use
- 1.1.5. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
  - 1.3.5.1. Data for primary interviews in North America
  - 1.3.5.2. Data for primary interviews in Europe
  - 1.3.5.3. Data for primary interviews in Asia Pacific
  - 1.3.5.4. Data for primary interviews in Latin America
  - 1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Procedure type outlook
- 2.2.4. End use outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Ligation Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing number of digestive diseases
  - 3.2.1.2. Technological advancement
  - 3.2.1.3. Increasing number of minimally invasive procedures
  - 3.2.1.4. Rising healthcare spending
  - 3.2.1.5. Increasing use of ligation devices in open surgery
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of surgeries and lack of reimbursement
  - 3.2.2.2. Post-surgical complications
3.3. Ligation Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. Ligation Devices Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Ligation Devices Market: Product Movement Analysis
4.3. Ligation Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Appliers
- 4.5.1. Appliers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Disposable
  - 4.5.2.1 Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Reusable
  - 4.5.3.1 Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Accessories
- 4.6.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Clips
  - 4.6.2.1 Clips Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Clips Removers
  - 4.6.3.1 Clips Removers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ligation Devices Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Ligation Devices Market: Application Movement Analysis
5.3. Ligation Devices Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Gastrointestinal and Abdominal Surgery
- 5.5.1. Gastrointestinal and Abdominal Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Gynecological Surgery
- 5.6.1. Gynecological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Cardiothoracic Surgery
- 5.7.1. Cardiothoracic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Urological Surgery
- 5.8.1. Urological Surgery Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Other
- 5.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ligation Devices Market: Procedure Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Ligation Devices Market: Procedure Type Movement Analysis
6.3. Ligation Devices Market by Procedure Type Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. MIS
- 6.5.1. MIS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Open Surgery
- 6.6.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ligation Devices Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Ligation Devices Market: End Use Movement Analysis
7.3. Ligation Devices Market by End Use Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Hospitals
- 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Ambulatory Surgical Centers
- 7.6.1. Ambulatory Surgical Centers Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Ligation Devices Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
- 8.5.1. U.S.
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework/ reimbursement structure
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
- 8.5.2. Canada
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework/ reimbursement structure
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
- 8.5.3. Mexico
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework/ reimbursement structure
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
8.6. Europe
- 8.6.1. UK
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework/ reimbursement structure
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.2. Germany
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework/ reimbursement structure
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.3. France
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework/ reimbursement structure
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.4. Italy
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework/ reimbursement structure
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.5. Spain
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework/ reimbursement structure
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.6. Norway
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework/ reimbursement structure
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.7. Sweden
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Regulatory framework/ reimbursement structure
  - 8.6.7.3. Competitive scenario
  - 8.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.8. Denmark
  - 8.6.8.1. Key country dynamics
  - 8.6.8.2. Regulatory framework/ reimbursement structure
  - 8.6.8.3. Competitive scenario
  - 8.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
8.7. Asia Pacific
- 8.7.1. Japan
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework/ reimbursement structure
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.2. China
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework/ reimbursement structure
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.3. India
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory framework/ reimbursement structure
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.4. Australia
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Regulatory framework/ reimbursement structure
  - 8.7.4.3. Competitive scenario
  - 8.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.5. South Korea
  - 8.7.5.1. Key country dynamics
  - 8.7.5.2. Regulatory framework/ reimbursement structure
  - 8.7.5.3. Competitive scenario
  - 8.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.6. Thailand
  - 8.7.6.1. Key country dynamics
  - 8.7.6.2. Regulatory framework/ reimbursement structure
  - 8.7.6.3. Competitive scenario
  - 8.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
8.8. Latin America
- 8.8.1. Brazil
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Regulatory framework/ reimbursement structure
  - 8.8.1.3. Competitive scenario
  - 8.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
- 8.8.2. Argentina
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework/ reimbursement structure
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
8.9. Middle East & Africa
- 8.9.1. South Africa
  - 8.9.1.1. Key country dynamics
  - 8.9.1.2. Regulatory framework/ reimbursement structure
  - 8.9.1.3. Competitive scenario
  - 8.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9.2. Saudi Arabia
  - 8.9.2.1. Key country dynamics
  - 8.9.2.2. Regulatory framework/ reimbursement structure
  - 8.9.2.3. Competitive scenario
  - 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9.3. UAE
  - 8.9.3.1. Key country dynamics
  - 8.9.3.2. Regulatory framework/ reimbursement structure
  - 8.9.3.3. Competitive scenario
  - 8.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9.4. Kuwait
  - 8.9.4.1. Key country dynamics
  - 8.9.4.2. Regulatory framework/ reimbursement structure
  - 8.9.4.3. Competitive scenario
  - 8.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
- 9.2.1. Innovators
9.2. Vendor Landscape
- 9.2.1. List of key distributors and channel partners
- 9.2.2. Key customers
- 9.2.3. Key company market share analysis, 2024
- 9.2.4. Medtronic
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. Johnson & Johnson Services, Inc.
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. The Cooper Companies, Inc.
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. CONMED Corporation.
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. B. Braun SE
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Teleflex Incorporated.
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. Olympus Corporation
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives

한글목차

결찰기 시장 성장과 동향

결찰기 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 결찰기 시장 변수, 동향, 범위

제4장 결찰기 시장 : 제품별, 추정·동향 분석

제5장 결찰기 시장 : 용도별, 추정·동향 분석

제6장 결찰기 시장 : 시술 유형별, 추정·동향 분석

제7장 결찰기 시장 : 최종 용도별, 추정·동향 분석

제8장 결찰기 시장 : 지역별, 추정·동향 분석